Study # HIPEC

Study Novel Targets and Immune Biomarkers from Patients with Peritoneal Metastasis under Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Gastric Cancer

Study Status:

Enrolling

Treatment Agent:

Hyperthermic Intraperitoneal Chemotherapy

Description

To collect patient specimens prior to and after HIPEC procedure, along with gastric cancer samples that are from non-HIPEC procedures to test for novel therapeutic additions to the current standard of care procedures. The focus is to find potential targets by studying the characteristics of the disease metastasis which will allow for better treatment options in the future.

Resources and Links

National Clinical Trial Identified Number: Not available

Information and next steps

Disease:

  • Gastric Cancer,
  • Peritoneal Metastasis

Study Phase:

Not applicable

Physician Name:

Department:

Ask a Question